AI predicts tumor-killing cells with high accuracy, study shows
Using artificial intelligence, Ludwig Cancer Research scientists have developed a powerful predictive model for identifying the most potent cancer-killing immune cells for use in cancer immunotherapies.
12 hours ago
0
3
Years after his death, late scientist's work could yield new cancer treatments
Some of the final work of a late University of Virginia School of Medicine scientist has opened the door for life-saving new treatments for solid cancer tumors, including breast cancer, lung cancer and melanoma.
8 hours ago
0
0
US geographic region results in vastly different anal cancer risk for people with HIV
A new study that followed a cohort of more than 110,000 people establishes significant disparities in the risk of anal cancer for people with HIV and for men who have sex with men with HIV, depending on the region of the ...
7 hours ago
0
0
Research shows altered regulation of genes linked to prostate cancer among firefighters
Firefighters may have an increased risk of prostate cancer due to on-the-job chemical exposures, according to new research from the University of Arizona Mel and Enid Zuckerman College of Public Health and University of Michigan ...
6 hours ago
0
0
Future research on bladder cancer should focus on mechanical changes in tissue, suggest study
In collaboration with University Hospital Basel, researchers from ETH are investigating the early stages of bladder cancer. Their findings show that future research should also focus on mechanical changes in tumor tissue.
8 hours ago
0
0
How TP53 gene loss drives gastric cancer evolution
Gastric cancer (GC) ranks as the fifth-most common and fourth-deadliest cancer worldwide, presenting significant health challenges, particularly in China, where it is most prevalent and accounts for nearly half of newly diagnosed ...
6 hours ago
0
0
Transfected SARS-CoV-2 spike DNA suppresses cancer cell response to chemotherapy
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 infection has led to worsened outcomes for patients with cancer. SARS-CoV-2 spike protein mediates host cell infection and cell-cell fusion that causes ...
10 hours ago
1
0
How the drug abemaciclib treats breast cancer
The anti-cancer drug abemaciclib (also known as Vernezio) has been added to the Australian Pharmaceutical Benefits Scheme (PBS) to treat certain types of breast cancer.
12 hours ago
0
0
New PET agent provides same-day imaging for clear cell renal cell carcinoma patients
A novel investigational PET imaging agent can rapidly and accurately visualize lesions in clear cell renal cell cancer (ccRCC) patients according to new research published in the May issue of The Journal of Nuclear Medicine.
6 hours ago
0
0
Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis and—eventually—treatment
A new study led by University of Michigan Health Rogel Cancer Center researchers identifies novel biomarkers in renal cell carcinomas. The researchers' integrative analysis of comprehensive proteogenomic datasets from both ...
May 6, 2024
0
7
Study uncovers at least one cause of roadblocks to cancer immunotherapy
T cells—the body's foot soldiers against invaders, ranging from everyday infections to cancers—are integral to many successful immunotherapies. However, a frustrating factor is that immunotherapies do not always work.
May 6, 2024
0
111
Study provides a blueprint of tumor-infiltrating B cells with therapeutic implications
In a study published in Science on May 3, researchers unveiled two responding patterns of tumor-infiltrating B cells with therapeutic implications.
May 6, 2024
0
29
Drug shows promise for starving out cancer cells
Starving out tumor cells may be a promising therapy for treatment-resistant lung cancer, according to a new study published in Science Advances.
May 6, 2024
0
26
Scientists track earliest cancer-triggering physical changes in cells
By the time cancer is diagnosed, a lot has already happened behind the scenes. Although cancers are classed into early and late stages for clinical purposes, even an "early" stage tumor is the result of many previous, undetectable ...
May 6, 2024
0
24
Knocking out deadly brain cancer with a dual therapy
Glioblastoma is an often fatal form of brain cancer, with only 5% of patients surviving beyond five years. The cancer is difficult to treat and almost always becomes resistant to treatment. As a result, recurrence of glioblastoma ...
May 6, 2024
0
1
New research examines past and guides future efforts to reduce cancer disparities
Investigators at Dana-Farber Cancer Institute have examined the historical evolution of Community Outreach and Engagement initiatives at both the National Cancer Institute (NCI) and National Cancer Institute-Designated Cancer ...
May 6, 2024
0
0
Researchers generate direct measurement of interaction between immune cells and cancer cells from a patient's biopsy
Researchers at Bar-Ilan University have unveiled a technology that promises to improve cancer treatment decisions based on a patient's biopsy. The pioneering biological research and development measures changes in immune ...
May 6, 2024
0
2
Exploring oncogenic driver molecular alterations in Hispanic/Latin American cancer patients
In an editorial, published in Oncoscience, researcher Rafael Parra-Medina from Fundación Universitaria de Ciencias de la Salud and Instituto Nacional de Cancerología discusses Latin America's (LA) population—a heterogeneous ...
May 6, 2024
0
0